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Objectives: Our aims were to confirm the relationship between lipid and 
lipoprotein concentrations and suicidal behaviour in first episode psychosis (FEP) 
patients.  
Methods: Suicidal behaviour was explored in a large FEP sample (N = 383). 
Baseline lipid profile was compared between those who attempted or completed suicide 
and those who not presented suicidal behaviour. 
Results: Low-density lipoprotein cholesterol (LDL-c) (OR=0.99, 95% CI= 0.98-
1.00) and depressive symptoms (OR=1.15, 95% CI=1.06-1.24) were significantly 
related with suicidal behaviour.  
Conclusions: Lipid profile test may be considered in the assessment of suicide 
risk in psychosis and LDL-c an important biological marker. 
















































Suicide represents the single most important cause of premature death in first 
episode psychosis (FEP) patients (Dutta et al. 2010). Earlier stages have been associated 
with higher risk periods. During the last decades, there has been a growing interest in 
the role of the low lipid and lipoprotein concentrations in suicidal behaviours, based on 
the observation of increased number of mortality from suicides, accidents or violence-
related after the use of cholesterol-lowering drugs (De Berardis et al. 2012).  
Lipid profile disturbances have been also reported in antipsychotic-naïve patients 
(Misiak et al. 2017). Moreover, lower total cholesterol (TC) and low-density lipoprotein 
cholesterol (LDL-c) levels have been found in patients diagnosed by schizophrenia with 
history of suicidal behaviours (Ainiyet and Rybakowski 2014). In addition, leptin, an 
adipocyte hormone involved in energy homeostasis, has been shown to be reduced in 
such patients (Atmaca et al. 2008). Also, significant low TC was found in FEP patients 
with history of suicidal behaviour (Marcinko et al. 2007). Indeed, Kavoor et al. (2017) 
found that schizophrenic patients with lower TC, and LDL-c tended to act impulsively 
and that low lipid profile increased the risk of self-harming behaviours (Kavoor et al. 
2017). In a sample of 35 psychiatric patients, low TC and leptin levels were also 
associated with more violent suicide attempts (Atmaca et al. 2008). 
The aims of our study were to confirm the association between lipid profile at 
baseline and suicidal behaviour occurred during a 3-year follow-up period in a large 
sample of antipsychotic-naïve FEP patients. Based on previous publications we 
hypothesized that 1) lower levels of TC, LDL and leptin will be associated with the 
presence of suicidal behaviours and 2) lower TC and leptin levels would correlate with 















































Data from this study came from a large epidemiological and 3-year longitudinal 
study of FEP program of Cantabria, Spain, (PAFIP) at the University Hospital Marqués 
de Valdecilla (Pelayo-Terán et al. 2008). The study was approved by the Marqués de 
Valdecilla University Hospital review board, and written informed consent was 
obtained from all subjects after complete description of the study. Three hundred and 
ninety seven patients met the inclusion criteria and were therefore included in the 
PAFIP program over this period (2001-2010). Baseline sociodemographic and clinical 
information was recorded for the total sample. Suicidal behaviours, i.e. "potentially self-
injurious behaviour for which the person intended to kill himself/herself" (Silverman, 
Alan L Berman, et al. 2007; Silverman, Alan L. Berman, et al. 2007), which 
encompasses suicide attempts and suicide completions, were taken from medical 
records, which provided information from patients, their families and medical staff. A 
complete description of the sociodemographic and clinical data have been described in 
elsewhere (Ayesa-Arriola et al. 2015). The differences between suicide attempters and 
non-attempters have been shown in supplementary material (see Table S1).  
The present study represents a secondary analysis drawn from a subset 
sample included in Ayesa-Arriola et al. (2015) (Ayesa-Arriola et al. 2015), to 
specifically test the association between lipid profile and suicide risk. Any 
participant presented physical illness possible interfering with lipid profile (e.g. 
hyperthyroidism, malnutrition, chronic anemia, cancer, or severe liver disease) or was 















































TC, high-density lipoproteins cholesterol (HDL-c), LDL-c and leptin were 
measured. To minimize the effects of diet and lab technique, blood samples were 
obtained between 8 and 10 am after overnight fasting by the same personnel, in the 
same setting. Samples were measured by automated methods on an Advia Centaur 
(SIEMENS, Erlangen, Germany). Serum cholesterol levels were measured by means of 
immunonephelometry in a Nephelometer Analyzer II (SIEMENS) using the reagents 
manufactured by SIEMENS. Intra- and inter-assay reproducibility were <5% and <7%, 
respectively. 
Statistical analyses 
The Statistical Package for Social Science, version 19.0 (IBM Corp. Released 
2010), was used for statistical analyses. All statistical tests were two-tailed, and 
significance was set at the 0.05 level. 
To test if FEP patients with suicidal behaviours presented different lipid profile 
ANCOVAs analyses were performed adjusted for age, sex and body mass index (BMI). 
To test if lower lipid profile correlated with high lethal method ANCOVAs analyses 
were performed adjusted for age, sex and BMI. 
Binary logistic regression (backward: conditional) was conducted to identify 
predictors of suicidal behaviour. Significant variables in the univariate analyses reported 
in Ayesa-Arriola et al. (Ayesa-Arriola et al. 2015) as well as significant variables found 
in the present study were included as predictors. 
 Results 
 ANCOVAs analyses confirmed that participants with the presence of suicidal 














































leptin (F=4.04; p<0.05) compared to those without suicidal behaviours (Table 1). There 
was no significant relationship between depressive symptomatology and any lipid 
component included in this study (information is available upon request).    
The regression model contained six independent variables: sex (p<0.03), depression 
(p<0.01), cannabis (p<0.04), TC (p<0.04), LDL-c (p<0.03) and leptin (p≤0.05) (Ayesa-
Arriola et al. 2015). Variance Inflation Factor (VIF) was calculated and there were no 
VIF´s values over 1.01, thus the assumption of multicollineality was not 
violated. Binary regression analysis showed that high scores in Calgary Depression 
Scale for Schizophrenia (CDSS) (OR=1.15, 95% CI=1.06-1.24) and low levels of LDL 
(OR=0.99, 95% CI=0.98-1.00) were significant independent parameters associated with 
suicidal behaviours.  
Discussion 
Our hypotheses were partially confirmed. In accordance with the first hypothesis, 
we found that lower baseline LDL-c levels were associated with increased risk of 
suicide behavior in a 3-year follow-up period after a FEP presentation. Regarding the 
second hypothesis, we failed to find significant relationship between low lipoprotein 
concentrations and more violent suicide methods. Although few studies have analysed 
the relationship between low serum lipid concentrations and violent suicidal behaviours 
in schizophrenic patients, significant relationship between low levels of TC, LDL-c 
(Kavoor et al. 2017) and leptin (Atmaca et al. 2008) and more violent suicide methods 
have been reported. The potential mechanism linking the lipid profile abnormality and 
elevated suicide risk/impulsivity are still unknown. With the aim of understanding the 
underlying mechanism, Lalovic et al., (Lalovic et al. 2007) examined cholesterol 
content in the brain tissue of suicide completers and found that those using violent 
methods had significantly lower cholesterol content in the frontal cortex compared to 














































prefrontal cortex. It has been postulated that deficits in the orbitofrontal cortex or in the 
ventral prefrontal cortex may result in impaired inhibition of impulses, and in turn, 
impulsive aggression and violent or suicidal behaviour. Lower cholesterol in the frontal 
cortex of violent suicide completers reported in this study supported the idea that 
deficits in specific areas within the frontal cortex may be linked to impaired inhibition 
of violent behaviours and suicide. We found a trend towards significant differences 
between those who used violent methods and those who used non-violent methods in 
the levels of TC (157.06±25.24 vs. 170.85±27.46, p=0.07) and leptin (4.87±5.70 vs. 
6.39±5.34, p=0.07).  Finally, not surprisingly, depression was associated with suicidal 
behaviour as extendedly previously reported (Challis et al. 2013). 
 A diathesis-stress model has been proposed to explain the relationship between 
lipoprotein concentrations and suicidal behaviour (Perez-Rodriguez et al. 2008). 
Diathesis model suggested the presence of a low lipid profile as a trait factor related to 
aggression/impulsivity. Serum lipids levels might influence behaviours such as 
impulsivity, aggression and suicide through their influences on serotonergic 
transmission in the brain. Serum lipids could play a role in the production of the myelin 
sheath, in transmembrane exchange, enzyme function, synthesis of steroid hormones 
and neurotransmitter receptor expression (De Berardis et al. 2012). A possible 
explanations is that leptin regulates dopamine responses to salient stress stimuli not 
directly linked to food. On the other hand, stress model sets forth that a low lipid profile 
could set off the suicidal behaviour. In our study, we found that exclusively low LDL-c 
level was independently associated with suicidal behaviour, which, according to the 
previous model mentioned, could act as a trait factor associated with 














































Some limitations need to be considered. Firstly, the design of the study did not 
allow to capture the dynamics of the lipids and their influence on suicidal behaviour. 
Secondly, although serotoninergic transmission, depends in part on brain cholesterol, 
experimental animal studies have demonstrated that brain cholesterol is relatively 
insulated from changes in circulating cholesterol. Thus, should be interpreted with 
caution. However, to the best of our knowledge no previous study has assessed the 
association between lipid profile with suicidal behaviours and suicidal methods in a 
such large sample of antipsychotic-naïve FEP patients. 
In conclusion, the role of low LDL-c in suicidal behaviour is supported by the 
results of this study. Suicide accounts for a large percentage of deaths in patients with 
FEP and other psychotic disorders and is an important health concern. Suicidal 
behaviour is far from clear and seems that it depends on different cultural, social, 
individual and biological factors in a complex interrelated relationship. However, most 
of evidence suggests that risk of suicidal behaviour is relatively high in FEP patients, 
being early intervention and correct management in FEP patients critical to minimize 
their suicidality (Pompili et al. 2011). The identification of a low lipid profile at 
baseline may contribute to improve accuracy in detecting high-risk patients and to 
develop or strengthen suicide prevention strategies in FEP patients during the early 
stages of the disorder. 
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Differences between FEP patients with suicidal and non-suicidal behaviors 
















176.37±39.14 162±60.46 176,38±40.59 F=4.49 0.04* 
HDL-c (mg/dL)
b 51.65±14.75 46.98±13.89 52.38±14.77 F=3.12 0.08 
LDL-c (mg/dL)
b 106.89±32.75 96.09±23.61 108.58±33.68 F=4.69 0.03* 
Leptin (mg/dl)
b 7.45±7.68 5.52±5.44 7.74±7.93 F=4.04 0.05* 
Triglycerides (mg/dL)
b 84.52±42.41 91.49±40.21 83.39±42.72 F=1.22 0.27 
Glucose (mg/dL)
b 87.24±17.50 90.31±38.09 86.73±10.80 F=2.20 0.14 
BMI 23.18±3.56 23.15±3.02 23.18±3.65 t=0.06 0.96 
FEP: First Episode of Psychosis; DUP: Duration Untreated Psychosis; BPRS: Brief Psychiatric Rating Scale; SAPS: Scale for the 
Assessment of Positive Symptoms; SANS: Scale for the Assessment of Negative Symptoms; CDSS: Calgary Depression Scale for 
Schizophrenia; SUMD: Scale of Unawareness of Mental Disorder; HDL-c: High-Density Lipoproteins- cholesterol; LDL-c: Low-
Density Lipoproteins-cholesterol; BMI: Body Mass Index.  
a Differences between patients with suicide attempts and without suicide attempts analyzed with chi-square, T-test and ANCOVA.  
b Controlled for sex, age and BMI. 
p<0.05   
Binary regression model in subsequent blocks (backward: conditional) with suicidal behavior 
(no/yes) as the dependent variable (n=332) 
 B SE Wald p OR 95%CI 
CDSS 0.14 0.04 11.39 0.01 1.15 1.06-1.24 
LDL-c -0.01 0.01 4.40 0.04 0.99 0.98-1.00 
x2 (3) = 18.58, p≤0.01, R2 Cox and Snell= 0.05, R2 Nagelkerke= 0.1 
CDSS: Calgary Depression Scale for Schizophrenia; LDL-c: Low-Density Lipoproteins-cholesterol 
p<0.05   
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